Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
25.40
+0.22 (0.87%)
At close: Jan 23, 2026
SHA:688298 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 2,431 | 3,081 | 4,165 | 6,597 | 6,098 | 2,039 | Upgrade |
Short-Term Investments | - | - | - | - | 31.15 | - | Upgrade |
Trading Asset Securities | 211.69 | 207.58 | 1,052 | 1,161 | 168.07 | 199 | Upgrade |
Cash & Short-Term Investments | 2,643 | 3,289 | 5,217 | 7,758 | 6,297 | 2,238 | Upgrade |
Cash Growth | -28.70% | -36.95% | -32.75% | 23.19% | 181.43% | 2519.03% | Upgrade |
Accounts Receivable | 226.66 | 230.17 | 207.74 | 309.36 | 1,184 | 625.82 | Upgrade |
Other Receivables | 10.44 | 19.12 | 20.7 | 73.13 | 53.96 | 43.83 | Upgrade |
Receivables | 237.11 | 249.28 | 228.44 | 382.49 | 1,238 | 669.65 | Upgrade |
Inventory | 332.05 | 308.96 | 346.78 | 431.92 | 470.56 | 381.58 | Upgrade |
Other Current Assets | 153.96 | 131.45 | 104.01 | 175.42 | 120.06 | 30.5 | Upgrade |
Total Current Assets | 3,366 | 3,979 | 5,896 | 8,747 | 8,126 | 3,319 | Upgrade |
Property, Plant & Equipment | 2,827 | 2,741 | 2,261 | 1,074 | 481.34 | 162.39 | Upgrade |
Long-Term Investments | 48.52 | 50.27 | 52.35 | 35.59 | 25.45 | - | Upgrade |
Goodwill | - | - | - | - | 15.41 | - | Upgrade |
Other Intangible Assets | 930.15 | 690.91 | 478.81 | 481.24 | 111.48 | 14.13 | Upgrade |
Long-Term Deferred Tax Assets | 272.74 | 268.47 | 218.26 | 193.23 | 69.68 | 45.46 | Upgrade |
Long-Term Deferred Charges | 47.88 | 59.71 | 61.05 | 36.32 | 7.37 | 5.08 | Upgrade |
Other Long-Term Assets | 15.43 | 305.85 | 28.05 | 135.63 | 139.81 | 26.82 | Upgrade |
Total Assets | 7,508 | 8,095 | 8,996 | 10,704 | 8,977 | 3,573 | Upgrade |
Accounts Payable | 479.04 | 515.49 | 600.49 | 1,580 | 1,174 | 371.97 | Upgrade |
Accrued Expenses | 41.97 | 72.03 | 68.45 | 218.81 | 175.55 | 97.64 | Upgrade |
Short-Term Debt | 103.26 | 116.78 | 198.22 | - | - | - | Upgrade |
Current Portion of Long-Term Debt | - | 300.22 | 50.3 | - | - | - | Upgrade |
Current Portion of Leases | 15.11 | 24.6 | 15.86 | 3.55 | 5.84 | - | Upgrade |
Current Income Taxes Payable | 6.2 | 3.41 | 3.77 | 17.67 | 606.85 | 309.31 | Upgrade |
Current Unearned Revenue | 33.25 | 30.99 | 34.77 | 339.14 | 71.19 | 325.7 | Upgrade |
Other Current Liabilities | 107.74 | 140.29 | 113.93 | 119.24 | 25.4 | 8.38 | Upgrade |
Total Current Liabilities | 786.58 | 1,204 | 1,086 | 2,278 | 2,059 | 1,113 | Upgrade |
Long-Term Debt | 159.09 | - | 300 | 50 | - | - | Upgrade |
Long-Term Leases | 28.94 | 47.17 | 43.96 | 28.65 | 12.65 | - | Upgrade |
Long-Term Unearned Revenue | 34.23 | 34.48 | 10.75 | 17.46 | 17.01 | 8.8 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.05 | 0.23 | 0.04 | 2.76 | - | - | Upgrade |
Other Long-Term Liabilities | 6.02 | 17.47 | 5.7 | 3.39 | - | - | Upgrade |
Total Liabilities | 1,015 | 1,303 | 1,446 | 2,381 | 2,088 | 1,122 | Upgrade |
Common Stock | 201.6 | 201.6 | 201.6 | 168 | 120 | 120 | Upgrade |
Additional Paid-In Capital | 397.89 | 397.89 | 395.42 | 436.32 | 549.21 | 549.21 | Upgrade |
Retained Earnings | 6,055 | 6,268 | 6,797 | 7,530 | 6,201 | 1,785 | Upgrade |
Treasury Stock | -326.94 | -276.95 | - | - | - | - | Upgrade |
Comprehensive Income & Other | 33.11 | 54.9 | 42.37 | 28.27 | -12.72 | -7.76 | Upgrade |
Total Common Equity | 6,361 | 6,645 | 7,436 | 8,163 | 6,857 | 2,446 | Upgrade |
Minority Interest | 132.14 | 146.34 | 113.66 | 160.15 | 31.62 | 5.37 | Upgrade |
Shareholders' Equity | 6,493 | 6,791 | 7,550 | 8,323 | 6,889 | 2,451 | Upgrade |
Total Liabilities & Equity | 7,508 | 8,095 | 8,996 | 10,704 | 8,977 | 3,573 | Upgrade |
Total Debt | 306.41 | 488.76 | 608.33 | 82.2 | 18.49 | - | Upgrade |
Net Cash (Debt) | 2,336 | 2,800 | 4,609 | 7,675 | 6,279 | 2,238 | Upgrade |
Net Cash Growth | -25.66% | -39.24% | -39.95% | 22.24% | 180.61% | 3729.37% | Upgrade |
Net Cash Per Share | 12.12 | 14.24 | 22.84 | 38.08 | 31.14 | 11.34 | Upgrade |
Filing Date Shares Outstanding | 191.58 | 193.2 | 201.6 | 201.6 | 201.6 | 201.6 | Upgrade |
Total Common Shares Outstanding | 191.58 | 193.2 | 201.6 | 201.6 | 201.6 | 201.6 | Upgrade |
Working Capital | 2,579 | 2,775 | 4,810 | 6,469 | 6,068 | 2,206 | Upgrade |
Book Value Per Share | 33.20 | 34.40 | 36.89 | 40.49 | 34.01 | 12.13 | Upgrade |
Tangible Book Value | 5,431 | 5,954 | 6,957 | 7,682 | 6,730 | 2,432 | Upgrade |
Tangible Book Value Per Share | 28.35 | 30.82 | 34.51 | 38.10 | 33.38 | 12.06 | Upgrade |
Buildings | - | 1,465 | 1,296 | 586.6 | 243.61 | 93.73 | Upgrade |
Machinery | - | 437.85 | 360.52 | 262.56 | 177.03 | 38.6 | Upgrade |
Construction In Progress | - | 1,134 | 796.48 | 369.99 | 112.45 | 70.29 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.